By following the investment decisions of some of the savviest private investors, Fund Twenty8 automatically builds you a diversified portfolio of no fewer than 28 EIS-qualifying startups. The portfolio of every iteration of Fund Twenty8 will be added to this page as they finish deploying.
Fund Twenty8-2017 portfolio
Fund Twenty8's 2017 portfolio consists of 32 investments spanning ten sectors. As our portfolio grows and raises further capital, we look forward to seeing its companies succeed.
FUND TWENTY8-2017 PORTFOLIO COMPANIES

Bockatech
ENGINEERING

Interpac
ENGINEERING

Greenspur Renewables
ENVIRONMENT

Naked Energy
ENVIRONMENT

Pass the Keys
MARKETPLACES

Pekama
MARKETPLACES

LuckyTrip
MARKETPLACES

Ambicare
LIFE SCIENCES

Arcis Biotechnology
LIFE SCIENCES

Cipher Surgical
LIFE SCIENCES

EnteroBiotix
LIFE SCIENCES

Gemetix Healthcare
LIFE SCIENCES

Molecular Warehouse
LIFE SCIENCES

MGB Biopharma
LIFE SCIENCES

Metrion Biosciences
LIFE SCIENCES
Fund Twenty8-2016 portfolio
The first Fund Twenty8 closed in 2017 and finished deploying in 2018. By September, the portfolio was valued at 108% (paper value). Its final portfolio is a testament to the fund's mission: to deliver investors a large and diversified portfolio of at least 28 investments.
- 233 investors took part
- Invested a total of £4.55m
- Diversified over 32 investments
- Across 10 sectors
FUND TWENTY8-2016 PORTFOLIO COMPANIES

Dymag
ENGINEERING

Alert Technology
ENVIRONMENT

USIO
ENVIRONMENT

Pekama
MARKETPLACES

Starstock
MARKETPLACES

Celame
MARKETPLACES

Biotechspert
MARKETPLACES

Make it Social
MARKETPLACES

e-Patient Network
HEALTHCARE

Dem DX
HEALTHCARE

Emoquo
HEALTHCARE

SupaPass
MEDIA

Peptinnovate
PHARMA

Re-Vana Therapeutics
PHARMA

Digital Therapeutics
PHARMA